Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

HPV vaccination may protect against adverse pregnancy outcomes

8

Oct 2026

HPV vaccination may protect against adverse pregnancy outcomes

Having received the human papillomavirus (HPV) vaccine before pregnancy is associated with a lower risk of major pregnancy complications including preterm birth, with the greater reduction in risk seen among women vaccinated at an earlier age, finds a large Swedish study published by The BMJ today.

HPV vaccination linked to lower risk of pregnancy complications

7

Oct 2026

HPV vaccination linked to lower risk of pregnancy complications

The benefits of the HPV vaccine may extend beyond protection against cancer. In a study published in The BMJ, researchers at Karolinska Institutet found that women who had been vaccinated against HPV were less likely to experience several pregnancy and childbirth complications, particularly preterm birth.

REUP technique expands access to pediatric heart transplants

7

Oct 2026

REUP technique expands access to pediatric heart transplants

A groundbreaking donor heart recovery technique developed at Vanderbilt Health has been successfully adapted for children by pediatric heart transplant surgeons at Monroe Carell Jr. Children's Hospital at Vanderbilt, potentially expanding access to lifesaving heart transplants for children.

Epilepsy drugs may reduce effectiveness of hormonal contraceptives

7

Oct 2026

Epilepsy drugs may reduce effectiveness of hormonal contraceptives

People with epilepsy who use certain hormonal birth control methods may be at risk for reduced contraceptive effectiveness because of interactions with certain antiseizure medications, according to a study published October 7, 2026, in Neurology, the medical journal of the American Academy of Neurology.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.